|
ARID4A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.17759970850318E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7248999995001E-07 |
| Normal-vs-Stage2 |
1.38059999998941E-06 |
| Normal-vs-Stage3 |
7.80020004143012E-09 |
| Normal-vs-Stage4 |
6.1620999969314E-08 |
| Stage1-vs-Stage2 |
2.972600E-01 |
| Stage1-vs-Stage3 |
1.580440E-01 |
| Stage1-vs-Stage4 |
8.620400E-02 |
| Stage2-vs-Stage3 |
9.918800E-01 |
| Stage2-vs-Stage4 |
7.309800E-01 |
| Stage3-vs-Stage4 |
6.847600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.13549997077445E-09 |
| Normal-vs-AfricanAmerican |
9.279600E-03 |
| Normal-vs-Asian |
2.23169999999939E-05 |
| Caucasian-vs-AfricanAmerican |
3.796200E-01 |
| Caucasian-vs-Asian |
9.104200E-01 |
| AfricanAmerican-vs-Asian |
4.945000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.99480012905451E-10 |
| Normal-vs-Female |
1.90519999776484E-08 |
| Male-vs-Female |
2.977200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.03009999999448E-06 |
| Normal-vs-Age(41-60Yrs) |
2.78580000179218E-08 |
| Normal-vs-Age(61-80Yrs) |
2.12639994501274E-09 |
| Normal-vs-Age(81-100Yrs) |
3.809600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.732000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.092000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.080000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.534200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.030600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.586400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.399000E-03 |
| Classical-VS-Follicular |
1.239080E-03 |
| Classical-VS-Other |
5.661200E-01 |
| Classical-VS-Normal |
4.44859999948477E-07 |
| Tall-VS-Follicular |
9.878800E-01 |
| Tall-VS-Other |
5.565800E-01 |
| Tall-VS-Normal |
6.67639999951675E-08 |
| Follicular-VS-Other |
6.397800E-01 |
| Follicular-VS-Normal |
6.48529996372105E-09 |
| Other-VS-Normal |
2.553600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.72390049089233E-10 |
| Normal-vs-N1 |
4.00040000014812E-07 |
| N0-vs-N1 |
8.081600E-01 |
|
|
